compound pharmacy and semaglutide The FDA announced that #semaglutide is no longer in shortage. That means compounding pharmacies like ours won't be able to them after April 22nd. Make sure you talk to your provider what is a compound pharmacy

Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

Informed Sport certified, it supports brain and cardiovascular health while increasing muscle strength, power, and lean mass

Review your health history and goals with a licensed medical provider

Modulatory effects of 1 Hz rTMS over the cerebellum on motor cortex excitability

Disclaimer: Ozempic, WeGovy, Saxenda and Victoza are registered trademarks of Novo Nordisk